EDGEMOND JAMES bought UTHR
November 4, 2025 · Form 4 insider transaction
EDGEMOND JAMES bought 21,000 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $3.07M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
21,000
Price
$146.03
Total value
$3.07M
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 4, 2025
Filing dateNovember 5, 2025
Shares owned after29,118
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.